DNA Methylation Pattern of Gene Promoters of MB-COMT, DRD2, and NR3C1 in Turkish Patients Diagnosed with Schizophrenia

키워드

참고문헌 (67)

1. McGrath J, "Schizophrenia : a concise overview of incidence, prevalence, and mortality", Epidemiol Rev, 30, pp.67~76 (2008)
2. Pepper E, "Genetics of schizophrenia and other psychotic disorders", Curr Psychiatry Rev, 10, pp.133~142 (2014)
3. Alelú-Paz R, "Epigenetics in schizophrenia : a pilot study of global DNA methylation in different brain regions associated with higher cognitive functions", Front Psychol, 7, pp.1496~ (2016)
4. Aytac HM, "Tumor necrosis factor-alpha(TNF-α)-238 G", A polymorphism is associated with the treatment resistance and attempted suicide in schizophrenia, 2020, 1~13
5. Pehlivan S, "Investigation of Catechol-O-Methyltransferase and Cannabinoid Receptor 2 gene variants in tobacco use disorder or tobacco use disorder and schizophrenia comorbidity", Alpha Psychiatry, 21, pp.572~578 (2020)
6. Jiménez-Jiménez FJ, "COMT gene and risk for Parkinson’s disease : a systematic review and meta-analysis", Pharmacogenet Genomics, 24, pp.331~339 (2014)
7. Aksoy S, "Catechol O-methyltransferase pharmacogenetics : photoaffinity labelling and western blot analysis of human liver samples", Pharmacogenetics, 3, pp.116~122 (1993)
8. Lotta T, "Kinetics of human soluble and membrane-bound catechol O-methyltransferase : a revised mechanism and description of the thermolabile variant of the enzyme", Biochemistry, 34, pp.4202~4210 (1995)
9. Craddock N, "The catechol-O-methyl transferase(COMT)gene as a candidate for psychiatric phenotypes : evidence and lessons", Mol Psychiatry, 11, pp.446~458 (2006)
10. Nour El Huda AR, "DNA methylation of membranebound catechol-O-methyltransferase in Malaysian schizophrenia patients", Psychiatry Clin Neurosci, 72, pp.266~279 (2018)
11. Myöhänen TT, "Distribution of catechol-O-methyltransferase(COMT)proteins and enzymatic activities in wild-type and soluble COMT deficient mice", J Neurochem, 113, pp.1632~1643 (2010)
12. Abdolmaleky HM, "Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder", Hum Mol Genet, 15, pp.3132~3145 (2006)
13. Nohesara S, "DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder", J Psychiatr Res, 45, pp.1432~1438 (2011)
14. Zahari Z, "A nested allele-specific multiplex polymerase chain reaction method for the detection of DRD2 polymorphisms", Malays J Med Sci, 18, pp.44~57 (2011)
15. Collins AG, "Opponent actor learning(OpAL) : modeling interactive effects of striatal dopamine on reinforcement learning and choice incentive", Psychol Rev, 121, pp.337~366 (2014)
16. Zou YF, "Association of DRD2 gene polymorphisms with mood disorders : a meta-analysis", J Affect Disord, 136, pp.229~237 (2012)
17. Conn KA, "Subcortical dopamine and cognition in schizophrenia : looking beyond psychosis in preclinical models", Front Neurosci, 14, pp.542~ (2020)
18. Serý O, "Polymorphism of DRD2 gene and ADHD", Neuro Endocrinol Lett, 27, pp.236~240 (2006)
19. Schäfer M, "Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D2 receptor gene", Am J Psychiatry, 158, pp.802~804 (2001)
20. Zahari Z, "Influence of DRD2polymorphisms on the clinical outcomes of patients with schizophrenia", Psychiatr Genet, 21, pp.183~189 (2011)
21. Zhang JP, "D2 receptor genetic variation and clinical response to antipsychotic drug treatment : a meta-analysis", Am J Psychiatry, 167, pp.763~772 (2010)
22. Yoshino Y, "Low methylation rates of dopamine receptor D2 gene promoter sites in Japanese schizophrenia subjects", World J Biol Psychiatry, 17, pp.449~456 (2016)
23. Pehlivan S, "Global and glucocorticoid receptor gene-specific(NR3C1)DNA methylation analysis in patients with cannabinoid or synthetic cannabinoid use disorder", Psychiatry Res, 298, pp.113774~ (2021)
24. Humphreys KL, "DNA methylation of HPA-axis genes and the onset of major depressive disorder in adolescent girls : a prospective analysis", Transl Psychiatry, 9, pp.245~ (2019)
25. Barker V, "Methylation of glucocorticoid receptor(NR3C1), BDNF and oxytocin receptor genes in association with childhood maltreatment in schizophrenia and schizoaffective disorder", Schizophr Res, 216, pp.529~531 (2020)
26. Vukojevic V, "Epigenetic modification of the glucocorticoid receptor gene is linked to traumatic memory and post-traumatic stress disorder risk in genocide survivors", J Neurosci, 34, pp.10274~10284 (2014)
27. Park S, "Associations between the neuron-specific glucocorticoid receptor(NR3C1)Bcl-1 polymorphisms and suicide in cancer patients within the first year of diagnosis", Behav Brain Funct, 12, pp.22~ (2016)
28. McDonald S, "Understanding the genetics and epigenetics of bulimia nervosa", bulimia spectrum disorder and comorbid borderline personality disorder(BN, Eat Weight Disord, pp.2019, 24[DOI]
29. Martín-Blanco A, "Association between methylation of the glucocorticoid receptor gene, childhood maltreatment, and clinical severity in borderline personality disorder", J Psychiatr Res, 57, pp.34~40 (2014)
30. Dogan MV, "Alcohol and tobacco consumption alter hypothalamic pituitary adrenal axis DNA methylation", Psychoneuroendocrinology, 66, pp.176~184 (2016)
31. Schote AB, "Glucocorticoid receptor gene variants and lower expression of NR3C1 are associated with cocaine use", Addict Biol, 24, pp.730~742 (2019)
32. Misiak B, "Clinical correlates of the NR3C1gene methylation at various stages of psychosis", Int J Neuropsychopharmacol, 24, pp.322~332 (2021)
33. World Medical Association, "World Medical Association Declaration of Helsinki : ethical principles for medical research involving human subjects", JAMA, 310, pp.2191~2194 (2013)
34. Kay SR, "The positive and negative syndrome scale(PANSS)for schizophrenia", Schizophr Bull, 13, pp.261~276 (1987)
35. Kostakoglu E, "Reliability and validity of the Turkish version of the Positive and Negative Syndrome Scale (PANSS)", Turk Psikoloji Dergisi, 14, pp.23~34 (1999)
36. Nohesara S, "Methamphetamineinduced psychosis is associated with DNA hypomethylation and increased expression of AKT1 and key dopaminergic genes", Am J Med Genet B Neuropsychiatr Genet, 171, pp.1180~1189 (2016)
37. Lind GE, "ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis", Cell Oncol, 28, pp.259~272 (2006)
38. Nishioka M, "Comprehensive DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia", J Hum Genet, 58, pp.91~97 (2013)
39. Brown AS, "Prenatal infection and schizophrenia : a review of epidemiologic and translational studies", Am J Psychiatry, 167, pp.261~280 (2010)
40. Arseneault L, "Childhood trauma and children’s emerging psychotic symptoms : a genetically sensitive longitudinal cohort study", Am J Psychiatry, 168, pp.65~72 (2011)
41. Selten JP, "Migration and schizophrenia", Curr Opin Psychiatry, 20, pp.111~115 (2007)
42. Vitale AM, "DNA methylation in schizophrenia in different patient-derived cell types", NPJ Schizophr, 3, pp.6~ (2017)
43. Ovenden ES, "DNA methylation and antipsychotic treatment mechanisms in schizophrenia : progress and future directions", Prog Neuropsychopharmacol Biol Psychiatry, 81, pp.38~49 (2018)
44. Huang HS, "GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia", PLoS One, 2, pp.e809~ (2007)
45. Abdolmaleky HM, "Hypermethylation of the reelin(RELN)promoter in the brain of schizophrenic patients : a preliminary report", Am J Med Genet B Neuropsychiatr Genet, 134B, pp.60~66 (2005)
46. Zhubi A, "An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes", Schizophr Res, 111, pp.115~122 (2009)
47. Carrard A, "Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder", J Affect Disord, 132, pp.450~453 (2011)
48. Abdolmaleky HM, "Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder", Schizophr Res, 129, pp.183~190 (2011)
49. Mill J, "Epigenomic profiling reveals DNA-methylation changes associated with major psychosis", Am J Hum Genet, 82, pp.696~711 (2008)
50. Ruzicka WB, "Circuit-and diagnosisspecific DNA methylation changes at γ-aminobutyric acid-related genes in postmortem human hippocampus in schizophrenia and bipolar disorder", JAMA Psychiatry, 72, pp.541~551 (2015)
51. Wockner LF, "Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients", Transl Psychiatry, 4, pp.e339~ (2014)
52. Goghari VM, "Differential association of the COMT Val158Met polymorphism with clinical phenotypes in schizophrenia and bipolar disorder", Schizophr Res, 103, pp.186~191 (2008)
53. Clelland CL, "Evidence that COMT genotype and proline interact on negative-symptom outcomes in schizophrenia and bipolar disorder", Transl Psychiatry, 6, pp.e891~ (2016)
54. Loch AA, "Epistasis between COMT Val158Met and DRD3 Ser9Gly polymorphisms and cognitive function in schizophrenia : genetic influence on dopamine transmission", Braz J Psychiatry, 37, pp.235~241 (2015)
55. Huang E, "Catechol-o-methyltransferase Val158Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizo-affective disorder patients : a meta-analysis", Int J Neuropsychopharmacol, 19, pp.pyv132~ (2016)
56. Walton E, "MB-COMT promoter DNA methylation is associated with working-memory processing in schizophrenia patients and healthy controls", Epigenetics, 9, pp.1101~1107 (2014)
57. Murphy BC, "Site-specific cytosine methylation in S-COMT promoter in 31 brain regions with implications for studies involving schizophrenia", Am J Med Genet B Neuropsychiatr Genet, 133B, pp.37~42 (2005)
58. Schizophrenia Working Group of the Psychiatric Genomics Consortium, "Biological insights from 108 schizophrenia-associated genetic loci", Nature, 511, pp.421~427 (2014)
59. Dempster EL, "Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder", Hum Mol Genet, 20, pp.4786~4796 (2011)
60. Kordi-Tamandani DM, "Analysis of association between dopamine receptor genes’methylation and their expression profile with the risk of schizophrenia", Psychiatr Genet, 23, pp.183~187 (2013)
61. Zhang AP, "The DNA methylation profile within the 5’-regulatory region of DRD2 in discordant sib pairs with schizophrenia", Schizophr Res, 90, pp.97~103 (2007)
62. Sinclair D, "Abnormal glucocorticoid receptor mRNA and protein isoform expression in the prefrontal cortex in psychiatric illness", Neuropsychopharmacology, 36, pp.2698~2709 (2011)
63. Sinclair D, "Glucocorticoid receptor 1B and 1C mRNA transcript alterations in schizophrenia and bipolar disorder, and their possible regulation by GR gene variants", PLoS One, 7, pp.e31720~ (2012)
64. Ripke S, "Genome-wide association analysis identifies 13 new risk loci for schizophrenia", Nat Genet, 45, pp.1150~1159 (2013)
65. Stein JL, "Identification of common variants associated with human hippocampal and intracranial volumes", Nat Genet, 44, pp.552~561 (2012)
66. 박주석, "NR3C1 Polymorphisms for Genetic Susceptibility to Schizophrenia", 생물정신의학, 26(2), pp.88~93 (2019), 대한생물정신의학회[DOI]
67. Liu L, "DNA methylation analysis of the NR3C1 gene in patients with schizophrenia", J Mol Neurosci, 70, pp.1177~1185 (2020)